The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application notesEndogenous content mapping by LM and EM ICC: 1/100. True dilution at user dilution: 1/32000. Optimal fixation: 0.1-2.5% glutaraldehyde,1% formaldehyde using HPI (High Performance Immunocytochemistry).
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
RelevanceGamma-aminobutyric acid (GABA) is a major inhibitory neurotransmitter. GABA acts at inhibitory synapses in the brain and spinal cord. Inhibition is provoked by GABA binding resulting in hyperpolarization of the synaptic transmembrane potential of the affected neuron. GABA binding causes ion channels to open allowing either the flow of chloride or potassium ions into or out of the cell.
Cellular localizationCell Membrane, Cytoplasmic, Plasma membrane and Secreted
4 aminobutanoic acid antibody
Gamma amino butyric acid antibody
Gamma aminobutyric acid antibody
References for Anti-GABA antibody (ab62669)
has not yet been referenced specifically in any publications.
Publishing research using ab62669? Please let us know so that we can cite the reference in this datasheet.
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"